Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
OREX | Orexigen Therapeutics, Inc. | Lynch Thomas P. | EVP. General Counsel & Sec. | May 31, 2017 | Option Exercise | $1.55 | 1,704 | 2,641 | 1,704 | Jun 02, 2017, 04:47 PM |
Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
OREX | Orexigen Therapeutics, Inc. | Lynch Thomas P. | EVP. General Counsel & Sec. | May 31, 2017 | Option Exercise | $1.55 | 1,704 | 2,641 | 1,704 | Jun 02, 2017, 04:47 PM |